Effects of fasudil in acute ischemic stroke: results of a prospective placebo-controlled double-blind trial. - Wikidata - wikimedia - TriplyDB

Effects of fasudil in acute ischemic stroke: results of a prospective placebo-controlled double-blind trial.

Effects of fasudil in acute ischemic stroke: results of a prospective placebo-controlled double-blind trial.

http://www.wikidata.org/entity/Q46591653

about

Interventions for deliberately altering blood pressure in acute stroke Calcium antagonists for acute ischemic stroke The Function of Rho-Associated Kinases ROCK1 and ROCK2 in the Pathogenesis of Cardiovascular Disease ROCKs as immunomodulators of stroke Metabolic actions of Rho-kinase in periphery and brain Small-molecule-induced Rho-inhibition: NSAIDs after spinal cord injury Modulating Astrocyte Transition after Stroke to Promote Brain Rescue and Functional Recovery: Emerging Targets Include Rho Kinase Rho kinase as a target for cerebral vascular disorders Inhibition of Plasmodium falciparum field isolates-mediated endothelial cell apoptosis by Fasudil: therapeutic implications for severe malaria APC/CCdh1-Rock2 pathway controls dendritic integrity and memory.Selective inhibition of brain endothelial Rho-kinase-2 provides optimal protection of an in vitro blood-brain barrier from tissue-type plasminogen activator and plasmin.Fasudil, a Clinically Used ROCK Inhibitor, Stabilizes Rod Photoreceptor Synapses after Retinal Detachment Rho-associated kinase activity is a predictor of cardiovascular outcomes.Rho kinase: A new target for treatment of cerebral ischemia/reperfusion injury.Rho kinase: an important mediator of atherosclerosis and vascular disease.Efficacy of Rho kinase inhibitor fasudil in secondary Raynaud's phenomenon Rho/Rho-associated coiled-coil forming kinase pathway as therapeutic targets for statins in atherosclerosis.Fasudil regulates T cell responses through polarization of BV-2 cells in mice experimental autoimmune encephalomyelitis.Rho-associated coiled-coil-forming kinases (ROCKs): potential targets for the treatment of atherosclerosis and vascular disease.Rho kinase as a therapeutic target in cardiovascular disease.RhoA and ROCK mediate histamine-induced vascular leakage and anaphylactic shock.Efficacy of Rho kinase inhibitor on cognitive impairment induced by chronic cerebral hypoperfusion in rats.Rho kinase regulates the survival and transformation of cells bearing oncogenic forms of KIT, FLT3, and BCR-ABL.RhoA/rock signaling mediates peroxynitrite-induced functional impairment of Rat coronary vessels Physiological role of ROCKs in the cardiovascular system Rho Kinase Inhibition as a Therapeutic for Progressive Supranuclear Palsy and Corticobasal Degeneration Applications for ROCK kinase inhibition Pharmacological treatment and prevention of cerebral small vessel disease: a review of potential interventions The therapeutic effects of Rho-ROCK inhibitors on CNS disorders.Antiepileptic effects of two Rho-kinase inhibitors, Y-27632 and fasudil, in mice Systematic review and stratified meta-analysis of the efficacy of RhoA and Rho kinase inhibitors in animal models of ischaemic stroke.Rho kinase (ROCK) inhibitors.Inhibition of ROCK activity allows InlF-mediated invasion and increased virulence of Listeria monocytogenes.Acute Rho-kinase inhibition improves coronary dysfunction in vivo, in the early diabetic microcirculation Increased leukocyte ROCK activity in patients after acute ischemic stroke.Rho-associated kinase activity is an independent predictor of cardiovascular events in acute coronary syndrome.Fasudil, a rho kinase inhibitor, limits motor neuron loss in experimental models of amyotrophic lateral sclerosis In search for geroprotectors: in silico screening and in vitro validation of signalome-level mimetics of young healthy state.Pharmacologic inhibition of ROCK2 suppresses amyloid-β production in an Alzheimer's disease mouse model.Rho-associated kinase activity, endothelial function, and cardiovascular risk factors.

P2860

Q24193073-5A5EFE6E-88BF-4F57-B6D2-775051F595DF Q24197865-F79A5536-9B39-4A36-81F8-20E5867B8715 Q26774795-B30D10F1-97E0-4619-8DD7-56255A28AA5C Q26853214-D10E9F4E-3FE2-4580-9BFD-BCBD42D7D57E Q26864028-F7F73A5D-4C2B-43E3-9AC0-F8357B479DCB Q27025964-0D30A3A2-9D68-41B3-A397-7172ECF59D90 Q28075887-0B73C41E-72C2-47D2-922B-58727F8EB910 Q28081507-576F8C6F-B348-4E27-A266-D43431956B0B Q28475706-116A1160-B4AE-4196-88AC-F70B3598AD87 Q33620199-48BD83E6-D985-489D-B66D-5A690A3E8114 Q33693655-E12C7AF2-E908-409B-A5AD-11609F8FEE5A Q33828265-2FA4D64B-2EF3-44EF-91AB-D921C8734F25 Q33911873-DA128A1A-7339-4229-ADE1-A8146CA4622A Q33936880-7FA48FC8-89C8-4ED2-B8F2-3E41BA27C9C7 Q33960580-801C357A-7186-4A29-9F02-23E05CCAEF93 Q34139690-98A22520-D79B-4CB7-BDC0-CFEBB522E11D Q34362144-840A07B2-BF0A-49AA-AA26-C404E6E71A16 Q34451923-A2608953-C182-4827-8AB6-A91442519189 Q34823543-4BC2EE26-318C-4867-B3A9-7E081F6B8DEF Q35352722-32B018E2-3B90-40FF-89A7-4AB21386B81C Q35377560-F7C74EAD-A9E1-4147-84B5-F639A408E2CC Q35480551-05B85105-6F37-4DED-8583-972F4350DBB4 Q35513750-02EA9B58-57BD-48B4-94C9-A87EE0B5D23C Q36159672-590E5F37-3881-4DAA-A07E-7C635F5E0870 Q36392528-A3475772-94BC-4F85-B5C9-D6B3B4DFF5AF Q36507768-03116E35-29D7-4808-AFBB-024DD9E89122 Q36649417-A67D9773-E190-476C-814D-B7C01239D163 Q36799847-91CAEF77-B386-46D0-89A0-83D3D45379E2 Q36818193-8ACDA159-F2D9-4B77-94BB-45CFD7745ACA Q36858308-FEA7DDAC-824F-4A4C-831B-88020DFB8C51 Q36880679-AE3A48AA-9574-44DE-9751-9CB46E7E819C Q36897945-16821AA4-48D5-48FF-9FBC-8668473A26E3 Q36955621-27674A92-EF0C-4D8A-8CA9-B1E9DFE429D7 Q37071805-BF2158E9-B5A2-491A-B7A2-FABD79BF1344 Q37107311-E2A47A38-78B4-408F-942F-9D319ADF8E80 Q37185006-A4A39CB2-25C4-4CE9-A44E-A83A523B4980 Q37327385-E60BA077-9DA9-44CB-AF97-EEB48BA9E5EA Q37361055-353EB2CB-3A5C-4922-A2AC-DF1921332CBC Q37362443-CD96A0A4-AE5E-4A75-8144-C630BBEF0113 Q37367339-5B0703B6-8E81-43B1-B098-105F6E13741F

P2860

Effects of fasudil in acute ischemic stroke: results of a prospective placebo-controlled double-blind trial.

http://www.wikidata.org/entity/Q46591653

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

2005年學術文章

@zh-hant

name

Effects of fasudil in acute is ...... controlled double-blind trial.

@en

Effects of fasudil in acute is ...... controlled double-blind trial.

@nl

type

label

Effects of fasudil in acute is ...... controlled double-blind trial.

@en

Effects of fasudil in acute is ...... controlled double-blind trial.

@nl

prefLabel

Effects of fasudil in acute is ...... controlled double-blind trial.

@en

Effects of fasudil in acute is ...... controlled double-blind trial.

@nl

P1433

Q46591653-66C55CAB-B6F1-4D3C-9FA7-679A36B10850

P1476

Q46591653-04AE98D4-6F97-41C3-A81E-604E3E75FD7A

P2093

Q46591653-0B1C7891-9DC0-453E-8E07-C122F0BEF968

Q46591653-1F94F934-6330-4FFE-A138-7158D8C1C41B

Q46591653-51D49A6A-467D-4383-98EB-681F2DFD300F

Q46591653-799A0009-3471-4489-917E-792CC60BBB2C

Q46591653-BBA88414-1077-4FB9-A270-705E3D7037F9

Q46591653-F86C4406-249D-49D2-90C9-D6670D8074CA

P304

Q46591653-AFD9CB66-2267-419F-A272-379C977FD2C2

P31

Q46591653-05B943B1-C1C9-4FDF-B085-C99271F43E2B

P356

Q46591653-D90747DF-F7B4-49A6-A3E4-52F0905B3C1B

P433

Q46591653-C1D7C742-7FF0-4806-8782-E0EEFFDDB679

P478

Q46591653-33201373-B7D1-4FED-BC84-3B772F86A49D

P577

Q46591653-789D908C-CE61-4EEF-A39C-0370EA76A976

P5875

Q46591653-DA04EB72-6C37-4987-872B-C1B0625C7846

P698

Q46591653-C6BAF70B-1875-4985-8D55-CAC2173C578C

P921

Q46591653-A934D28B-9E1A-4846-84B0-C0C0705051B9

P356

J.JNS.2005.06.003

P1433

Journal of the Neurological Sciences

P1476

Effects of fasudil in acute is ...... controlled double-blind trial.

@en

P2093

Eiichi Ohtomo

http://www.w3.org/2001/XMLSchema#string

Fasudil Ischemic Stroke Study Group

http://www.w3.org/2001/XMLSchema#string

Masato Shibuya

http://www.w3.org/2001/XMLSchema#string

Minoru Seto

http://www.w3.org/2001/XMLSchema#string

Shin-ichi Satoh

http://www.w3.org/2001/XMLSchema#string

Shunsaku Hirai

http://www.w3.org/2001/XMLSchema#string

P304

31-39

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JNS.2005.06.003

http://www.w3.org/2001/XMLSchema#string

P433

1-2

http://www.w3.org/2001/XMLSchema#string

P478

238

http://www.w3.org/2001/XMLSchema#string

P577

2005-07-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7738450

http://www.w3.org/2001/XMLSchema#string

P698

16005902

http://www.w3.org/2001/XMLSchema#string

P921